Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 2020 , Vol 11, Issue 4
Evaluation of Thromboprophylaxis After Cesarean Section
İsmail Bıyık1
1Karacabey Devlet Hastanesi, Kadın Hastalıkları ve Doğum, Bursa, Türkiye DOI : 10.31067/0.2020.276 Purpose: The indications and the efficacy of enoxaparin-induced thromboprophylaxis after the cesarean section in Karacabey State Hospital were evaluated.

Patients and methods: A total of 611 births were performed between 1 January 2018 and 31 December 2018 in ** Hospital. Three hundred and twenty-eight (54%) pregnant women were delivered by cesarean section. Twenty-two (7%) pregnant women who were delivered by cesarean section underwent enoxaparin and 10 days postpartum thromboprophylaxis. Patients were called for control on the 11th postoperative day. In their control, DVT was questioned in terms of pulmonary embolism, drug allergy, bleeding, injection site reaction.

Results: The mean age of the patients was 29.68 ± 6.02 years. The most indication was repeated cesarean section 9 (40.9%). The most common thromboprophylaxis indication was obesity 12 (54.5%). Thirteen (59.1%) patients were given enoxaparin 60 mg / day and 9 (40.9%) had enoxaparin (40 mg / day). None of the patients had DVT, pulmonary embolism or enoxaparin-related complications.

Conclusion: In this study, it was found that the administration of low molecular weight heparin and thromboprophylaxis was effective and safe for pregnant women with high-medium risk for thromboembolism. Keywords : Postpartum thromboprophylaxis, cesarean section, enoxaparin, deep vein thrombosis, pulmonary embolism